Trials / Completed
CompletedNCT04762615
Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Impact of the Immunosuppressive Treatment, X-ray Exposition and Renal Pathology on Ovarian Reserve in Young Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 153 (actual)
- Sponsor
- Wroclaw Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 44 Years
- Healthy volunteers
- Not accepted
Summary
Aging, renal pathology (eg SLE, ADPKD), X-ray exposition and pharmacological treatments, especially previous strong immunosuppression, may negatively influence the ovarian reserve in childbearing age women. Anti-Müllerian hormone (AMH) is regarded as biomarker for ovarian reserve. Every female with renal disease regularly menstruating that met exclusion criteria could have participated. The aim was to assess ovarian reserve in female patients with normal menstrual cycle and kidney disease, including kidney transplant recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | AMH level measurement | AMH level measurement using ELISA test from blood samples |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2019-11-10
- Completion
- 2020-12-01
- First posted
- 2021-02-21
- Last updated
- 2021-02-21
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04762615. Inclusion in this directory is not an endorsement.